Fulvestrant extends hormonal therapy options in breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1473, 2005-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fulvestrant brings new options in breast cancer

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Fulvestrant - A Novel Endocrine Therapy for Breast Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 10, 2010-04 ,pp. : 902-914

Bentham Science Publishers

Access to resources Recommend Favorite

Value offered by therapy options in breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 491, 2005-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health

By Journé Fabrice Body Jean-Jacques Leclercq Guy Laurent Guy

Expert Opinion on Drug Safety, Vol. 7, Iss. 3, 2008-05 ,pp. : 241-258

Informa Healthcare

Access to resources Recommend Favorite

Emerging data on the efficacy and safety of fulvestrant, a unique antiestrogen therapy for advanced breast cancer

By Scott Sarah M Brown Myles Come Steven E

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 819-826

Informa Healthcare

Access to resources Recommend Favorite